1. Home
  2. AVPT vs VCEL Comparison

AVPT vs VCEL Comparison

Compare AVPT & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AvePoint Inc.

AVPT

AvePoint Inc.

N/A

Current Price

$11.52

Market Cap

2.0B

Sector

Technology

ML Signal

N/A

Logo Vericel Corporation

VCEL

Vericel Corporation

N/A

Current Price

$46.80

Market Cap

1.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AVPT
VCEL
Founded
2001
1989
Country
United States
United States
Employees
3443
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.7B
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
AVPT
VCEL
Price
$11.52
$46.80
Analyst Decision
Buy
Strong Buy
Analyst Count
12
5
Target Price
$16.64
$57.75
AVG Volume (30 Days)
2.5M
720.8K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
60.00
EPS
N/A
N/A
Revenue
N/A
$276,259,000.00
Revenue This Year
$25.00
$19.40
Revenue Next Year
$19.63
$18.24
P/E Ratio
$1,348.94
N/A
Revenue Growth
N/A
16.45
52 Week Low
$8.84
$28.95
52 Week High
$19.95
$47.06

Technical Indicators

Market Signals
Indicator
AVPT
VCEL
Relative Strength Index (RSI) 64.31 76.08
Support Level $11.49 $32.47
Resistance Level $14.33 N/A
Average True Range (ATR) 0.46 1.66
MACD 0.09 0.58
Stochastic Oscillator 88.73 97.36

Price Performance

Historical Comparison
AVPT
VCEL

About AVPT AvePoint Inc.

AvePoint Inc is a provider of modern data protection, enabling organizations to secure, govern, and operationalize data at scale across cloud ecosystems. Customers rely on the AvePoint Confidence Platform to reduce risk, improve operational efficiency, and accelerate digital transformation as it adopt cloud collaboration and artificial intelligence (AI)-driven developed tools and workflows. Its products and services are sold throughout the world, through direct and indirect sales channels.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: